you are so right bobby! shareholders are too optimistic and positive in their investment choices. we need more pessimism and negativity. let us know how we can help accomplish this. thanks for all you do!
LP has to offer guidance and an acceptable business case at the ASM, if not concrete action in whatever form that might take.The ASM cannot be another empty shell.
Nonsense, journal publications lead to mass media coverage and then lead to investor interest, and often strong interest from potential investors. It also leads to new doctors learning about the treatment which creates demand both for the UK Specials Program as well as eventually for the approved treatment.
Further, it appears that the UK is well positioned to advance this rapidly and to find patients prior to NICE approval for NHS.